Palonosetron, second generation 5-HT3 antagonist: a new perspective in CINV management. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 7, 2009. DOI: 10.4081/hmr.v2i7.414. Disponível em: https://journals.pagepress.org/hmr/article/view/414. Acesso em: 20 jun. 2025.